Skip to content

The Effectiveness of neuroregulation for the Prevention of Postherpetic Neuralgia

The Effectiveness of Single Epidural Injection And Another Paravertebral Injection with Local Anesthetics and Steroids for the Prevention of Postherpetic Neuralgia in Patients with Acute Herpes Zoster

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011538
Enrollment
Unknown
Registered
2017-06-01
Start date
2017-06-05
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post herpetic neuralgia

Interventions

A:a single epidural injection and then a single repetitive paravertebral injection with local anesthetics and steroids
B:oral administration of 800 mg acyclovir, 5 times daily for 7 days, and analgesics as needed

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with HZ-associated pain diagnosed 1–7 days after the onset of the rash, dermatome below C3, aged older than 55 years, sufficient command of the chinses language, willingness to comply with the allocated treatment and follow-up measurements.

Exclusion criteria

Exclusion criteria: coagulation abnormalities, infection of the skin overlying the vertebra of the affected dermatome, psychiatric diseases, drug allergy, and known serious immune disorders.

Design outcomes

Primary

MeasureTime frame
The presence of zoster associated pain 1 month after inclusion;

Secondary

MeasureTime frame
Presence and severity of pain at other time points were secondary endpoints;

Countries

China

Contacts

Public ContactDu Dongping

Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China

dudongping0101@163.com+86 15221956258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026